Alvotech Stock (NASDAQ: ALVO) stock price, news, charts, stock research, profile.
Open | $14.000 |
Close | $14.150 |
Volume / Avg. | 248.476K / 298.347K |
Day Range | 14.000 - 14.230 |
52 Wk Range | 6.700 - 18.000 |
Market Cap | $3.978B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 65 |
Short Interest | 0.22% |
Days to Cover | 1.71 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alvotech (NASDAQ: ALVO) through any online brokerage.
Other companies in Alvotech’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Alkermes (NASDAQ:ALKS) and SpringWorks Therapeutics (NASDAQ:SWTX).
The latest price target for Alvotech (NASDAQ: ALVO) was reported by Barclays on Friday, March 22, 2024. The analyst firm set a price target for 20.00 expecting ALVO to rise to within 12 months (a possible 40.55% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Alvotech (NASDAQ: ALVO) is $14.23 last updated April 26, 2024 at 5:56 PM EDT.
There are no upcoming dividends for Alvotech.
Alvotech’s Q1 earnings are confirmed for Thursday, May 16, 2024.
There is no upcoming split for Alvotech.
Alvotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.